Search Within

Manuel Alejandro Sepulveda

Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (3)
  2. GSK Faculty (3)
  3. Melanoma and Immunotherapeutics Service (3)
  4. Solid Tumor Oncology Division (3)
  5. Center for Hematologic Malignancies (2)
  6. Executive Committee, Center for Hematologic Malignancies (2)

More Groups

People
  1. James Allison (3)
  2. Alan Houghton (2)
  3. Amanda Holland (2)
  4. Arnab Ghosh (2)
  5. Christopher King (2)
  6. Daniel Hirschhorn Cymerman (2)

More People

Years
  1. 2014 (1)
  2. 2013 (3)
  3. 2009 (1)
  4. 2008 (1)
Publications
  1. Journal of Experimental Medicine (2)
  2. Journal of Immunology (2)
  3. Biology of Blood and Marrow Transplantation (1)
  4. Blood (1)
Publishers
  1. Rockefeller University Press (2)
  2. The American Association of Immunologists, Inc (2)
  3. American Society of Hematology (1)
  4. Elsevier Inc. (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy
    Journal Article

    Fan, X.; Quezada, S. A.; Sepulveda, M. A.; Sharma, P.; Allison, J. P.
    Journal of Experimental Medicine (2014)

    Fulltext@MSK | Save
  • Chronic inflammatory liver disease in mice expressing a CD28-specific ligand
    Meeting Abstract

    Corse, E.; Gottschalk, R.; Park, J. S.; Sepulveda, M.; Loke, P.; Sullivan, T.; Johnson, L.; Allison, J.
    Journal of Immunology (2013)

    Fulltext@MSK | Save
  • Fc-dependent depletion of tumor-infiltrating regulatory t cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma
    Journal Article

    Simpson, T. R.; Li, F.; Montalvo Ortiz, W.; Sepulveda, M. A.; Bergerhoff, K.; Arce, F.; Roddie, C.; Henry, J. Y.; Yagita, H.; Wolchok, J. D.; more...
    Journal of Experimental Medicine (2013)

    Fulltext@MSK | Save
  • Cutting edge: Chronic inflammatory liver disease in mice expressing a CD28-specific ligand
    Journal Article

    Corse, E.; Gottschalk, R. A.; Park, J. S.; Sepulveda, M. A.; Loke, P.; Sullivan, T. J.; Johnson, L. K.; Allison, J. P.
    Journal of Immunology (2013)

    Fulltext@MSK | Save
  • The T cell cytolytic molecules fas ligand and trail, the trafficking molecules Ccr9, 7 integrin and psgl1, and the immune modulating molecules ox40 and ceacam1 are required for thymic graft-versus-host disease
    Meeting Abstract

    Lu, S. X.; Na, I. K.; Goldberg, G. L.; Ghosh, A.; Hirschhorn-Cymerman, D.; King, C. G.; Smith, O. M.; Suh, D.; Rao, U.; Yim, N.; more...
    Biology of Blood and Marrow Transplantation (2009)

    Fulltext@MSK | Save
  • The T cell cytolytic molecules Fas ligand and TRAIL, the trafficking molecules CCR9, β7 integrin and PSGL-1, and the immune modulating molecules OX40, CEACAM1, and CTLA4 are required for thymic graft-versus-host disease
    Meeting Abstract

    Na, I. K.; Lu, S. X.; Goldberg, G. L.; Hirschhorn Cymerman, D. D.; King, C. G.; Smith, O. M.; Suh, D.; Rao, U.; Yim, N.; Holland, A. M.; more...
    Blood (2008)

    Fulltext@MSK | Save